IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml

7680627190013 CH-62719 M05BA06 07.99.0.

Active substances:

IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml
IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6271901
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
acidum ibandronicum 3 mg ut natrii ibandronas monohydricus, acidum aceticum glaciale, natrii acetas trihydricus, natrii chloridum, natrii hydroxidum aut acidum aceticum glaciale q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 12.53 mg.

Articles (1)

Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/08/2026
Professional SmPC
Français
01/08/2026
Professional SmPC
Italien
01/08/2026

Detailed composition

Substance Quantity Type Category
acidum ibandronicum
3.0 MG Substance Wirkstoff (Principe actif)
natrii ibandronas monohydricus
- Substance WIZUS
acidum aceticum glaciale
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
12.53 MG Substance HBESI

Reimbursement information

Public price
CHF 62.55
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2014

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62719
Drug name
Ibandronat-Mepha Osteo i.v., Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
M05BA06
Authorization status
Z
Dispensation category
B
First authorization
20/11/2013
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml
Description (DE)
IBANDRONAT Mepha Osteo 3 mg/3ml i.v. Fertspr 3 ml
Market launch
20/11/2013
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
CHF 210.75
View original
Buy us a coffee Explore the data